Skip to content

Blog

Category: Industry Update

The Impact of Brexit on European Biotech and Biopharma

At the commencement of her national campaign in July 2016, the former UK Prime Minister Theresa May stated, “It is hard to think of an…

Read More

What’s Happening at the 14th WRIB Virtual Meeting?

We've compiled a guide to the presentations & forums our BioAgilytix team members will be participating in throughout the 2020 WRIB Virtual Meeting so you…

Read More

The Power of Being NYCE

A recent study using triple-edited ‘NYCE’ cells shows the possibilities of multiplex genome editing to effectively treat complex diseases like some cancers. We explore the…

Read More

A Dose of Pharma and Biotech News: December 12, 2019

With innovative research driving pharmaceutical and biotech breakthroughs, industry progress is accelerating at a rapid pace. We've compiled some recent industry articles on the latest…

Read More

Event Line-Up: The Bioanalytical Industry Forums We’ll Be at This Fall

We're looking forward to participating in several upcoming bioanalytical conferences and events this fall, ranging from small-circle workshops to global, world-renowned industry forums.

Read More

Key Takeaways from the 13th Annual WRIB, 2019

Last month at WRIB, our scientific team had the opportunity to participate in a number of discussions surrounding the latest topics of interest in biomarkers,…

Read More

Immunogenicity Assessment of Gene Therapy Compounds

By Dr. Arno Kromminga and Dr. Lydia Michaut

Gene therapy has experienced an exciting resurgence in the post-genomic era, but unwanted immunogenicity is still a…

Read More

Key Takeaways from Oxford Global’s 14th Annual Biomarkers Congress

Couldn’t make the Oxford Global’s 14th Annual Biomarkers Congress? Read our recap of the key opportunities and challenges in biomarker development that scientists discussed.

Read More

The FDA’s Response to an Increase in the Development of Gene and Cell Therapies: What It Means for Sponsors

...material, gene therapy uses DNA to manipulate a patient’s cells to compensate for abnormal genes or to make a beneficial protein, and cell therapy

Read More

Biomarkers and Immunogenicity in the Spotlight at the 2016 10th Workshop on Recent Issues in Bioanalysis

The whitepaper based on discussions at the 10th Workshop on Recent Issues in Bioanalysis (WRIB) has been published! Everyone who participated, are very excited to…

Read More